Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2017

Feb 3, 2017

29745_dirs_2017-02-03_d81e47f6-0293-4bc2-b8e1-9c6561aa32b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-02-01

Reporting Person: Ricks David A (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-01 Common Stock M 10244 Acquired 109400 Direct
2017-02-01 Common Stock F 4837 $77.03 Disposed 104563 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-01 Restricted Stock Unit $ M 10244 Disposed 2017-02-01 Common Stock (10244.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4989 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.